Madison-based Nimble Therapeutics Inc. will collaborate with Roche Diagnostics for faster discovery and optimization of compounds for detecting SARS-CoV-2, according to a statement.
The company is working to develop in vitro diagnostic assays for SARS-CoV-2, the virus that causes COVID-19.
